Farm the turd -- beat the herd
Followers | 88 |
Posts | 10,527 |
Boards Moderated | 4 |
Alias Born | 02/17/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nice perspective
CIGX 3.8 wall
Rare earth elements
BUY Recommendation
April 25, 2011
Star Scientific, Inc.
( Nasdaq – CIGX – 3.64 )
We continue our Buy Recommendation on CIGX shares. There are four major reasons:
1) A likely licensing agreement for Star’s BDL (Below Detectable Levels) Modified Risk (i.e. Safe or at the very least much Safer ) Tobacco Products (of ALL kinds – cigarettes, chewing tobacco, alternatives, etc.). This could occur any day and would probably include an upfront payment and future royalty stream. Star would then have immediate profits, recurring revenue and recurring profits, and per share earnings upon which to value this aspect of the story. Our estimate, as discussed under “BDL” immediately below, is that CIGX could be earning $1.00 per share (untaxed but per fully diluted 170 million shares) in a year from this BDL technology alone.
2) We expect the Federal Appellate Court to rule on Star’s suit against Reynolds American (RAI-36.28) within two months (possibly one). If that ruling is as favorable as we believe it could/should be, Star might (eventually) win trebled damages of $2 billion or higher from Reynolds. Philip Morris (Atria – MO – 26.06) would be next in line for a substantially higher amount. Substantially meaning a multiple of $2 billion.
3) A new and very aggressive posture from Star against Reynolds (maybe MO and others in the Tobacco Industry as well) will likely follow the Appellate ruling -- maybe leading to settlements, a friendly acquisition of a part of Star’s Technologies (the Patent Litigation aspect) and/or unfriendly takeover attempts. We believe that as soon as a favorable opinion comes down from the Federal Appellate Court – probably in May or June – this part of the Star story will become very active and exciting. A Jury Trial could be scheduled for sometime late this year.
4) And finally, Star seems to have developed what appears to be a patented Technology Platform which could be a treatment or even a cure for many serious diseases – such as Alzheimer’s, Thyroid, Arthritis, Heart, Stoke and important others. That really seems too preposterous for many to believe. However, unlikely as this may seem to some/many/even most (including a heavy weighting of Shorts), evidence of this possibility continues to arise from various sources. If true, CIGX shares would seem to have pretty much open-ended potential on top of the significant BDL and Litigation potentials.
added GFRE, traded EXK... nice bounce
out of SCEI on rumors
added CCCL, p/e of 2 here. eom
Nibbling SCEI 4.05, bought some MDW 1.99, YUII 5.88. EXK, AVL, CIGX on watch
Newmont Mining (NEM) Raised To Buy Hold By GMP
To busy on paltalk, lol
Excellent, I am back in AVL...great info Jo, keep it up! See you on paltalk~
Night land
The Trend Trader For Stock Trading on Monday, April 25, 2011
http://www.stocksmansion.com/stocks-news/the-trend-trader-for-stock-trading-on-monday-april-25-2011/
RCON - 8K , also TRIT same
Item 4.01 Changes in Registrant’s Certifying Accountant.
The practice of Bernstein & Pinchuk LLP (“B&P”), the Registrant’s independent registered public accounting firm, entered into a joint venture agreement with Marcum LLP and formed Marcum Bernstein & Pinchuk LLP (“MarcumBP”) in a transaction pursuant to which B&P merged its China operations into Marcum BP and certain of the professional staff of B&P joined MarcumBP as employees of MarcumBP (“Merger”). Accordingly, effective April 18, 2011, B&P effectively resigned as the Registrant’s independent registered public accounting firm and MarcumBP became the Registrant’s independent registered public accounting firm. This change in the Registrant’s independent registered public accounting firm was approved by the Audit Committee of the Registrant’s Board of Directors on April 18, 2011.
B&P’s reports on the financial statements of the Registrant as of and for the fiscal year ended June 30, 2010 did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. B&P did not audit the Registrant’s financial statements for the year ended June 30, 2009. For a discussion of B&P’s appointment as the Registrant’s independent public accounting firm, please refer to the Current Event on Form 8-K filed on October 19, 2009 (SEC Accession No. 0001193125-09-209609).
During the fiscal year ended June 30, 2010 and through the effective date of the Merger, there were no disagreements with B&P on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which if not resolved to B&P’s satisfaction would have caused it to make reference thereto in connection with its reports on the financial statements for such periods. During the fiscal year ended June 30, 2010 and through April 18, 2011, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K. Notwithstanding the foregoing, the Registrant engaged in the sort of ordinary discussion that would be expected between a company and its auditor with personnel of B&P who became personnel of MarcumBP upon completion of the Merger.
During the fiscal year ended June 30, 2010 and through April 18, 2011, the effective date of the Merger, the Registrant did not consult with MarcumBP with respect to any of (i) the application of accounting principles to a specified transaction, either completed or proposed; (ii) the type of audit opinion that might be rendered on the Registrant’s financial statements; or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K) or an event of the type described in Item 304(a)(1)(v) of Regulation S-K.
The Registrant provided B&P with a copy of the foregoing disclosure and requested B&P to furnish it with a letter addressed to the U.S. Securities and Exchange Commission stating whether it agrees with the statements made therein. A copy of the letter, dated April 22, 2011, furnished by BP, is filed as Exhibit 16.1 to this Current Report on Form 8-K.
(SVA) Sinovac Files Annual Report on Form 20-F
Must be pretty terrible.
"The Company will provide a hard copy of its complete audited financial statements to its shareholders free of charge upon request. Requests for a hard copy of the 2010 annual report can be processed by visiting the Investor Relations section of the Company's website and filling in the complete mailing details on the Contact IR page."
Sino Clean Energy, Inc. Announces Appointment of Independent Director 04/21 02:10 PM
On April 15, 2011, the board of directors (the “Board”) of Sino Clean Energy, Inc. (the “Company”) received notification from Mr. Albert Ching-Hwa Pu that effective immediately, he resigned as a member of the Board of the Company. At the time of his resignation, Mr. Pu also served as Chairman of the Audit Committee and a member of the Compensation Committee and Nominating and Corporate Governance Committee. Mr. Pu resigned for personal reasons and there were no disagreements between him and the Company on any matter relating to the Company’s operations, policies or practices, which resulted in his resignation. A copy of his resignation letter, dated April 15, 2011, is included with this 8-K as Exhibit 99.1.
On April 15, 2011, the Board appointed Mr. Brock Silvers as a director and a member of the Audit Committee. The Board determined that Mr. Silvers is an “independent director” as that term is defined in accordance with Rule 5605(a)(2) of the Marketplace Rules of The NASDAQ Stock Market, LLC and Section 10A(m)(3) of the Securities Exchange Act of 1934, as amended.
Mr. Silvers, aged 46, has more than two decades of senior investment and operating experience in China and Asia, with a specific emphasis on the energy industry. He currently serves as Managing Director of Kaiyuan Capital, a China-focused PE fund, and is a board director with China Energy Corporation (OTC:CHGY), a leading Chinese coal mining company. Mr. Silvers previously served as CEO of Laris Group, a China-based hospitality portfolio, and as CEO of Envirofit International, an environmental technology firm operating in the Asia Pacific region. Mr. Silvers was also a co-founding Partner of Power Pacific Company, a private equity firm focused exclusively on Chinese energy industry investments, and served as Director of International Development for Eagle In dustries, a multi-billion dollar industrial holding company controlled by renowned U.S. investor Sam Zell. He received his MBA in Finance from the Wharton School of University of Pennsylvania, his M.A. in International Studies (Chinese Language & Culture) from the Lauder Institute of University of Pennsylvania, and his B.A. in Chinese Studies from Columbia University. Mr. Silvers is fluent in Chinese.
On April 15, 2011, the Company and Mr. Silvers executed a director offer letter (the “Offer Letter”) in connection with Mr. Silvers’ appointment, pursuant to which Mr. Silvers will be entitled to receive an annual compensation of $24,000 for his services rendered. In addition, the Company granted Mr. Silvers an option to purchase up to 10,000 shares of the Company’s common stock at an exercise price equal to the closing price of the Company’s common stock on the date of the Offer Letter for a period of six years. The option will be exercisable one year after the date of the Offer Letter. The Company will reimburse Mr. Silvers for reasonable expenses incurred in connection with his performance of duties as a director of the Company, including travel expenses. The Company also agrees to include Mr. Silvers as an insured under its directors and officers insurance policy and indemnify Mr. Silvers for any expenses incurred in connection with his performance of duties as a director of the Company.
Top 10 U.S.-Listed Chinese Stocks with Highest Return on Assets: SCEI, SCOK, CNET, CDM, CYOU, CHNR, BIDU, GPRC, ZSTN, LPH (Apr 23, 2011)
http://www.cnanalyst.com/2011/04/top-10-us-listed-chinese-stocks-with-highest-return-on-assets-scei-scok-cnet-cdm-cyou-chnr-bidu-gprc-1.html
GM likely to retake No. 1 sales spot from Toyota
http://finance.yahoo.com/news/GM-likely-to-retake-No-1-apf-3689232429.html?x=0
Nasdaq ’Threshold’ Securities for April 21
http://www.bloomberg.com/news/2011-04-22/nasdaq-threshold-securities-for-april-21-table-.html?cmpid=yhoo
Nasdaq ’Threshold’ Securities for April 21
http://www.bloomberg.com/news/2011-04-22/nasdaq-threshold-securities-for-april-21-table-.html?cmpid=yhoo
Top 10 Most Efficient U.S.-Listed Chinese Stocks: CEO, SGOC, LPH, CHNR, ZSTN, HGSH, CBEH, YONG, XNY, CSKI (Apr 22, 2011)
http://www.cnanalyst.com/2011/04/top-10-most-efficient-us-listed-chinese-stocks-ceo-sgoc-lph-chnr-zstn-hgsh-cbeh-yong-xny-cski-apr-22.html
Best-Performing U.S.-Listed International Stocks Year-to-Date (Apr 22, 2011)
http://www.cnanalyst.com/2011/04/best-performing-us-listed-international-stocks-year-to-date-apr-22-2011.html
join us the in the paltalk chat next trading day! we've discussed biopharm fda plays, ree's etc. anything fair game that makes $$
As well as a scam, this is not a China growth stock.
NO PINKS / NO SUBPENNIES. NO EXCEPTION.
yes, yes i am.
Nasdaq Seeks Tougher Rules on Reverse Mergers
http://www.thestreet.com/story/11090882/1/nasdaq-seeks-tougher-rules-on-reverse-mergers.html?cm_ven=RSSFeed
Happy Easter CGS! Hope everyone has a well deserved break.